|Bid||10.65 x 1500|
|Day's Range||13.95 - 14.25|
|52 Week Range||7.95 - 17.20|
|PE Ratio (TTM)||190.54|
|Earnings Date||Jul 26, 2017 - Jul 31, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||21.71|
SOUTH SAN FRANCISCO, Calif., May 15, 2017-- Cytokinetics, Incorporated today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration has granted orphan drug designation ...
Anika focuses on pain management, tissue regeneration and wound healing.
SOUTH SAN FRANCISCO, Calif., May 11, 2017-- Cytokinetics, Incorporated today announced that its Annual Meeting of Stockholders will be held on Thursday, May 18, 2017 at 10:30 AM Pacific Time at the Embassy ...